Perinatal Psychoactive Substances Use: A Rising Perinatal Mental Health Concern

Author:

ELNahas Gihan1ORCID,Thibaut Florence2ORCID

Affiliation:

1. Neuropsychiatry Department, Ain Shams Medical School, Cairo 11591, Egypt

2. University Hospital Cochin (Site Tarnier), University of Paris Cité, AP-HP, INSERM U1266, Institute of Psychiatry and Neurosciences, 75006 Paris, France

Abstract

Introduction: A significant increase in psychoactive drugs use was observed in women of childbearing age and during the perinatal period worldwide. Yet, the use of illicit drugs, alcohol and tobacco during pregnancy is a serious health risk for the mother, developing fetus and newborn. Methods: This review of current trends and consequences of psychoactive substance use in the general population and in pregnant women was conducted using the English and French literature published during the years 2000 to 2022, supplemented by guidelines, meta-analyses and reviews. Results: According to current rates of prenatal substances use, it was calculated that 380,000 offspring were exposed to illicit substances, more than 500,000 to alcohol and over one million to tobacco during uterine life. Alarmingly, drug-related pregnancy-associated mortality has shown a staggering 190% rise between 2010 and 2019 in the USA. Different drugs of abuse, when used during pregnancy, increase the risk of stillbirth, neonatal abstinence syndrome and sudden infant death. Adverse effects on pregnancy include premature rupture of membranes, placental abruption, preterm birth, low birth space? weight and small-for-gestational-age infants. There is also an increased risk of morbidity and mortality for the pregnant women. Long-term negative adverse effects of perinatal exposure to substances also include a number of neurocognitive, behavioral and emotional dysfunctions in infants. Each type of substance has its own specificities, which will be briefly summarized. Conclusion: All childbearing age women must be informed about the potential harm of the prenatal use of psychoactive substances and should be encouraged to stop their use when pregnancy is planned and, at least, when pregnancy is known. Questioning women about their alcohol consumption should be systematic at the first prenatal visit and then at every prenatal visit until delivery. Multidisciplinary prevention approaches as well as intervention measures targeted to each type of psychoactive substance can save mothers’ lives and mitigate serious adversities to the offspring.

Publisher

MDPI AG

Subject

General Medicine

Reference59 articles.

1. Alert out on tobacco and alcohol consumption in young European women;Thibaut;Eur. Arch. Psychiatry Clin. Neurosci.,2018

2. (2023, February 07). Available online: https://www.unodc.org/wdr2018/prelaunch/WDR18_Booklet_4_YOUTH.pdf.

3. (2023, February 07). Perinatal Drug Abuse And Neonatal Drug Withdrawal, Available online: https://www.ncbi.nlm.nih.gov/books/NBK519061/.

4. Caffeine use during pregnancy: Prevalence of use and newborn consequences in a cohort of French pregnant women;Lamy;Eur. Arch. Psychiatry Clin. Neurosci.,2021

5. (2023, February 07). Women and Alcohol in the, EU. Available online: https://eurohealth.ie/women-and-alcohol-in-the-eu/.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3